NPI: 1417297821 · MOUNTAIN HOME, ID 83647 · Family Medicine Physician · NPI assigned 02/21/2013
Authorized official FOWLER, KATHRYN controls 18+ related entities in our dataset. Read more
| Authorized Official | FOWLER, KATHRYN (SENIOR VP, CFO) |
| Parent Organization | ST LUKES REGIONAL MEDICAL CENTER LTD |
| NPI Enumeration Date | 02/21/2013 |
Other providers sharing the same authorized official: FOWLER, KATHRYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,028 | $1.02M |
| 2019 | 17,017 | $1.04M |
| 2020 | 14,169 | $956K |
| 2021 | 14,735 | $961K |
| 2022 | 17,647 | $1.14M |
| 2023 | 12,996 | $994K |
| 2024 | 8,352 | $748K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 34,564 | 30,777 | $5.23M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29,222 | 27,981 | $1.02M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 1,479 | 1,457 | $126K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,082 | 1,061 | $119K |
| 87428 | 1,822 | 1,813 | $97K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,740 | 3,535 | $84K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,775 | 3,748 | $50K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 881 | 873 | $44K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 473 | 473 | $35K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 521 | 519 | $17K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,167 | 2,428 | $11K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 6,112 | 6,017 | $9K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 151 | 151 | $7K |
| 99238 | Hospital discharge day management, 30 minutes or less | 26 | 25 | $2K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3,369 | 3,134 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 91 | 89 | $1K |
| 71046 | Radiologic examination, chest; 2 views | 62 | 62 | $864.75 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 79 | 77 | $852.16 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,736 | 1,732 | $706.70 |
| 90832 | Psychotherapy, 30 minutes with patient | 19 | 13 | $674.74 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,529 | 1,433 | $565.36 |
| 81003 | 334 | 303 | $492.27 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 26 | 26 | $399.28 |
| 99215 | Prolong outpt/office vis | 288 | 277 | $295.71 |
| 73630 | 22 | 13 | $256.80 | |
| 90686 | 1,700 | 1,698 | $206.57 | |
| 87807 | 15 | 15 | $199.80 | |
| 90656 | 48 | 48 | $71.16 | |
| J3490 | Unclassified drugs | 122 | 112 | $63.47 |
| 36415 | Collection of venous blood by venipuncture | 18 | 17 | $43.36 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 46 | 44 | $41.46 |
| 90474 | 249 | 248 | $36.19 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 688 | 680 | $27.68 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 15 | 15 | $12.35 |
| 81002 | 240 | 170 | $9.39 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 76 | 74 | $6.75 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 14 | 14 | $1.16 |
| 90647 | 290 | 289 | $0.00 | |
| 90723 | 366 | 365 | $0.00 | |
| 90688 | 52 | 52 | $0.00 | |
| 90680 | 214 | 213 | $0.00 | |
| 96127 | 208 | 207 | $0.00 | |
| 99383 | 12 | 12 | $0.00 | |
| 91307 | 18 | 16 | $0.00 | |
| 90619 | 12 | 12 | $0.00 | |
| 90651 | 25 | 25 | $0.00 | |
| 99177 | 14 | 14 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 967 | 963 | $0.00 |
| 90670 | 714 | 712 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 132 | 132 | $0.00 |
| 91300 | 18 | 16 | $0.00 | |
| 90633 | 75 | 75 | $0.00 | |
| 99382 | 13 | 13 | $0.00 | |
| 90734 | 13 | 13 | $0.00 |